ML-IAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ML-IAP Antibodies for research focused on understanding ML-IAP protein functions. ML-IAP monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ML-IAP, or Melanoma Inhibitory Activity Protein, plays a critical role in regulating apoptosis and cell survival, making it an important target in cancer research. By inhibiting caspase activity, ML-IAP contributes to the resistance of cancer cells to programmed cell death, which is a significant factor in tumor progression and treatment resistance. Understanding ML-IAP function is essential for developing targeted therapies aimed at overcoming this resistance. ML-IAP research has revealed significant insights into cancer cell survival mechanisms and potential therapeutic targets. Ongoing studies continue to uncover new aspects of ML-IAP's role in cancer progression and treatment resistance. Current research focuses on understanding how ML-IAP influences different cancer types and treatment outcomes. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge cancer research by enabling precise detection and analysis of ML-IAP in various experimental settings.